All posts tagged
Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A
More News! GSK’s Pipeline Shakeup, Bayer’s Failure & an EU Investigation
Bayer and Evotec Extend their Endometriosis Partnership
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
Where to Find the Perfect Mix of International and German Biotechs? Berlin!
How the CRISPR-Cas9 System is Redefining Drug Discovery
FDA Speeds Up the Approval Process for Bayer’s New Lymphoma Drug
What’s Berlin’s Secret to Success in Biotech & Digital Health?
Which European Blockbusters Topped the Charts in 2016?
Epigenetics Drug Improves Survival in the Second Deadliest Cancer
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
UPDATE: Bayer seals deal with Monsanto in Dark Side slide
Labiotech UG, All Rights Reserved -
Send this to a friend